155 related articles for article (PubMed ID: 20237898)
41. [Effect of ceramide on apoptosis of human colon cancer HT-29 cells].
Zhang XF; Li BX; Ren R
Wei Sheng Yan Jiu; 2006 Sep; 35(5):537-40. PubMed ID: 17086696
[TBL] [Abstract][Full Text] [Related]
42. Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway.
Chen GG; Liang NC; Lee JF; Chan UP; Wang SH; Leung BC; Leung KL
Apoptosis; 2004 Sep; 9(5):619-27. PubMed ID: 15314290
[TBL] [Abstract][Full Text] [Related]
43. Vitex rotundifolia Fruit Extract Induces Apoptosis Through the Downregulation of ATF3-Mediated Bcl-2 Expression in Human Colorectal Cancer Cells.
Song HM; Park GH; Koo JS; Jeong HJ; Jeong JB
Am J Chin Med; 2017; 45(4):901-915. PubMed ID: 28468511
[TBL] [Abstract][Full Text] [Related]
44. Effects of genistein on the polyamine metabolism and cell growth in DLD-1 human colon cancer cells.
Linsalata M; Russo F; Notarnicola M; Guerra V; Cavallini A; Clemente C; Messa C
Nutr Cancer; 2005; 52(1):84-93. PubMed ID: 16091008
[TBL] [Abstract][Full Text] [Related]
45. STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells.
Bhattacharya S; Ray RM; Johnson LR
Biochem J; 2005 Dec; 392(Pt 2):335-44. PubMed ID: 16048438
[TBL] [Abstract][Full Text] [Related]
46. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells.
Dasiram JD; Ganesan R; Kannan J; Kotteeswaran V; Sivalingam N
Biomed Pharmacother; 2017 Feb; 86():373-380. PubMed ID: 28011386
[TBL] [Abstract][Full Text] [Related]
47. Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells.
Messa C; Notarnicola M; Russo F; Cavallini A; Pallottini V; Trentalance A; Bifulco M; Laezza C; Gabriella Caruso M
Scand J Gastroenterol; 2005 Dec; 40(12):1454-61. PubMed ID: 16293557
[TBL] [Abstract][Full Text] [Related]
48. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells.
Kandouz M; Siromachkova M; Jacob D; Chretien Marquet B; Therwath A; Gompel A
Int J Cancer; 1996 Sep; 68(1):120-5. PubMed ID: 8895551
[TBL] [Abstract][Full Text] [Related]
49. 17-beta-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A.
Jenkins JK; Suwannaroj S; Elbourne KB; Ndebele K; McMurray RW
Int Immunopharmacol; 2001 Oct; 1(11):1897-911. PubMed ID: 11606022
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of the proliferation of human gastric cancer cells SGC-7901 in vitro and in vivo using Bcl-2 siRNA.
Hao JH; Gu QL; Liu BY; Li JF; Chen XH; Ji YB; Zhu ZG; Lin YZ
Chin Med J (Engl); 2007 Dec; 120(23):2105-11. PubMed ID: 18167184
[TBL] [Abstract][Full Text] [Related]
51. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.
Jelínková I; Šafaříková B; Vondálová Blanářová O; Skender B; Hofmanová J; Sova P; Moyer MP; Kozubík A; Kolář Z; Ehrmann J; Hyršlová Vaculová A
Biochem Pharmacol; 2014 Dec; 92(3):415-24. PubMed ID: 25285768
[TBL] [Abstract][Full Text] [Related]
52. Small interfering RNA of cyclooxygenase-2 induces growth inhibition and apoptosis independently of Bcl-2 in human myeloma RPMI8226 cells.
Li QB; Chen ZC; You Y; Zou P
Acta Pharmacol Sin; 2007 Jul; 28(7):1031-6. PubMed ID: 17588340
[TBL] [Abstract][Full Text] [Related]
53. Diallyl disulfide induces apoptosis in human colon cancer cell line (COLO 205) through the induction of reactive oxygen species, endoplasmic reticulum stress, caspases casade and mitochondrial-dependent pathways.
Yang JS; Chen GW; Hsia TC; Ho HC; Ho CC; Lin MW; Lin SS; Yeh RD; Ip SW; Lu HF; Chung JG
Food Chem Toxicol; 2009 Jan; 47(1):171-9. PubMed ID: 19038304
[TBL] [Abstract][Full Text] [Related]
54. Induction of apoptosis of SW480 human colon cancer cells by (-)-epicatechin isolated from Bulnesia sarmienti.
Kim D; Mollah ML; Kim K
Anticancer Res; 2012 Dec; 32(12):5353-61. PubMed ID: 23225437
[TBL] [Abstract][Full Text] [Related]
55. Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin.
Funato T; Satou J; Kozawa K; Fujimaki S; Miura T; Kaku M
Oncol Rep; 2001; 8(4):807-10. PubMed ID: 11410788
[TBL] [Abstract][Full Text] [Related]
56. Targeting c-Myb expression in human disease.
Ramsay RG; Barton AL; Gonda TJ
Expert Opin Ther Targets; 2003 Apr; 7(2):235-48. PubMed ID: 12667100
[TBL] [Abstract][Full Text] [Related]
57. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma.
Alitalo K; Winqvist R; Lin CC; de la Chapelle A; Schwab M; Bishop JM
Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4534-8. PubMed ID: 6589609
[TBL] [Abstract][Full Text] [Related]
58. Estrogen and progesterone modulate monocyte cell cycle progression and apoptosis.
Thongngarm T; Jenkins JK; Ndebele K; McMurray RW
Am J Reprod Immunol; 2003 Mar; 49(3):129-38. PubMed ID: 12797519
[TBL] [Abstract][Full Text] [Related]
59. B-cell leukemia protein-2 and peptide YY chemotherapy resistance in colon cancer.
Kling K; Kim F; Cole M; McFadden D
Am J Surg; 1999 Nov; 178(5):411-4. PubMed ID: 10612539
[TBL] [Abstract][Full Text] [Related]
60. Presence of circulating anti-c-myb oncogene product antibodies in human sera.
Sorokine I; Ben-Mahrez K; Bracone A; Thierry D; Ishii S; Imamoto F; Kohiyama M
Int J Cancer; 1991 Mar; 47(5):665-9. PubMed ID: 2004847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
